Currently out of the existing stock ratings of Tara Bancroft, 16 are a BUY (80%), 4 are a HOLD (20%).

Tara Bancroft

Work Performance Price Targets & Ratings Chart

Analyst Tara Bancroft, currently employed at TD COWEN, carries an average stock price target met ratio of 53.89% that have a potential upside of 29.31% achieved within 90 days.

Tara Bancroft’s has documented 40 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on LNTH, Lantheus Holdings at 03-Aug-2026.

Wall Street Analyst Tara Bancroft

Analyst best performing recommendations are on PCVX (VAXCYTE ).
The best stock recommendation documented was for OCUL (OCULAR THERAPEUTIX) at 6/14/2024. The price target of $7 was fulfilled within 26 days with a profit of $1.25 (21.74%) receiving and performance score of 8.36.

Average potential price target upside

DAWN Day One Biopharmaceuticals GERN Geron LNTH Lantheus Holdings OCUL Ocular Therapeutix PCVX Vaxcyte  PTGX Protagonist Therapeutics VRNA Verona Pharma PLC ADR

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 21-Jun-2021

$21.5

$-0.03 (-0.14%)

$27

Buy Since 15-Dec-2022

$21.5

$-0.03 (-0.14%)

$22

Buy Since 21-Jun-2021

$21.5

$-0.03 (-0.14%)

$30

Buy Since 27-Feb-2024

$21.5

$-0.03 (-0.14%)

$20

Show more analysts

Please expand the browser size to see the chart

Which stock is Tara Bancroft is most bullish on?

Potential upside of $2.53 has been obtained for LNTH (LANTHEUS HOLDINGS)

Which stock is Tara Bancroft is most reserved on?

Potential downside of -$54.32 has been obtained for PTGX (PROTAGONIST THERAPEUTICS)

What Year was the first public recommendation made by Tara Bancroft?

On 2024

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?